Delivery Order SPE2DB22D1202-SPE2DB25FVDR3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Botox 100 unit vials valued at $10,336.32. This firm fixed-price delivery order, with a completion date of August 11, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation, indicating open competition. This delivery order is a child contract issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of BOTOX 100 unit vials with a ceiling value of $1,722.72. This firm fixed price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 25, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX, valued at $4,306.80, on June 18, 2025, with an ultimate completion date of July 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,306.80 to AmerisourceBergen Drug Corp for the supply of Botox 100 Unit Vials. This firm fixed price, competitively awarded contract was issued on July 23, 2025, with an ultimate completion date of August 13, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $85,479.00 for Botox 200-unit vials on June 26, 2025, with completion targeted for July 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Botox 100-unit vials, with a ceiling value of $2,153.40 and an ultimate completion date of June 24, 2025. This non-competitive delivery order carries firm fixed pricing and represents a competitive award under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is...
- The Defense Logistics Agency awarded a $2,564.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials, with an ultimate completion date of August 15, 2025. This non-set-aside competitive award was issued on July 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's existing relationship with DLA for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of BOTOX 100 Unit Vials with a ceiling value of $43,068.00. This firm fixed-price delivery order, with an ultimate completion date of July 18, 2025, represents a competitive award with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's extensive pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX under a firm fixed-price contract valued at $5,168.16. The award was made on August 4, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside delivery order represents a continuation of the company's role as a critical pharmaceutical supplier to the federal government, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,564.37 to supply Botox 200 unit vials, with an ultimate completion date of August 20, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVDR3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Botox 100 unit vials with a ceiling value of $2,584.08. This is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under a larger contract vehicle, specifically the company's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive range of medications and medical supplies to military and veteran healthcare systems. The company maintains a significant portfolio of federal contracts with the Defense Logistics Agency covering diverse pharmaceutical products, specialty medications, and medical devices across multiple therapeutic domains. This delivery order for Botox represents a specialized medical product procurement within the company's broader capacity to fulfill federal healthcare supply requirements through its comprehensive prime vendor agreement with DLA Troop Support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 6/30/25 |